Equities

Cerus Corp

Cerus Corp

Actions
Health CareMedical Equipment and Services
  • Price (EUR)1.74
  • Today's Change-0.013 / -0.74%
  • Shares traded1.00k
  • 1 Year change+19.31%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments66102129
Total Receivables, Net363425
Total Inventory402927
Prepaid expenses3.224.565.82
Other current assets, total------
Total current assets144170187
Property, plant & equipment, net192325
Goodwill, net1.321.321.32
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets312122
Total assets198218237
LIABILITIES
Accounts payable243336
Accrued expenses222728
Notes payable/short-term debt000
Current portion long-term debt/capital leases205615
Other current liabilities, total2.000.590.67
Total current liabilities6811779
Total long term debt601455
Total debt807069
Deferred income tax------
Minority interest0.790.951.00
Other liabilities, total171919
Total liabilities145150153
SHAREHOLDERS EQUITY
Common stock0.180.180.17
Additional paid-in capital1,0981,0771,049
Retained earnings (accumulated deficit)(1045)(1007)(964)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.27)(2.79)(0.15)
Total equity536885
Total liabilities & shareholders' equity198218237
Total common shares outstanding181178174
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.